We conclude that the observed gene upregulation could be explained by epigenetic changes and propose that AMER1, HSPA2, NCX1, and TNFRSF10C may contribute to the clinical effects of AZA in MDS. The gene discussed is TNFRSF10C; the disease is myelodysplastic syndrome.